Oncosil Medical Ltd has released a press release.
OSL Secures $5.6 million from Major Institutional Investors
Earlier from Oncosil Medical
- OncoSil Receives FDA Approval for Distal Cholangiocarcinoma
- OncoSil Medical Completes Manufacturing Validation
- OncoSil Medical Files for FDA Approval
- OncoSil Selected for Major European Pancreatic Cancer Study